Clinical Trials
5 trialsNCT01552434 2026-05-15
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02523040 2025-12-10
Lenalidomide for Adult Histiocyte Disorders
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT06712810 2025-10-10
Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Phase 1 Recruiting
NCT04079179 2025-09-18
NACHO-COBI
Baylor College of Medicine
Phase 2 Recruiting
NCT05915208 2025-06-11
Histiocytic Disorder Follow-up Study
University of Alabama at Birmingham
Recruiting